D. E. Shaw & Co., Inc. Novartis Ag Call Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $1.09 Million - $1.21 Million	11,500 New	11,500 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $226,650 - $277,560	3,000 New	3,000 $272,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $3.25 Million - $3.83 Million	-38,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $3.33 Million - $3.67 Million	38,900 New	38,900 $3.38 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.